Nazanin Alavi
1, 2
, MD, FRCPC ;
Callum Stephenson
1, 2
, BScH ;
Shadé Miller
1
, MD ;
Payam Khalafi
1
, MD ;
Israa Sinan
3
;
Danielle Kain
4
, MD ;
Maggie McDougall
5
, RSW, MSW ;
Julia Davies
5
, RSW, MSW ;
Debora Stark
5
, RSW, MSW, RMFT, CCFT ;
Erin Tompkins
5
, RSW, MSW ;
Jasleen Jagayat
1
, BScH ;
Mohsen Omrani
6
, MD, PhD ;
Amirhossein Shirazi
1, 2, 6
, MD, PhD ;
Dianne Groll
1
, PhD ;
Claudio Soares
1
, MD, PhD, FRCPC, MBA
1
Department of Psychiatry, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
2
Centre for Neuroscience Studies, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
3
Faculty of Arts and Science, Queen's University, Kingston, ON, Canada
4
Department of Medicine, Queen's University, Kingston, ON, Canada
5
Supportive Care Program, Cancer Centre of Southeastern Ontario, Kingston Health Sciences Centre, Kingston, ON, Canada
6
OPTT Inc, Toronto, ON, Canada
Corresponding Author:
-
Nazanin Alavi, MD, FRCPC
-
Department of Psychiatry
-
Faculty of Health Sciences
-
Queen's University
-
Hotel Dieu Hospital
-
166 Brock Street
-
Kingston, ON, K7L 5G2
-
Canada
-
Phone:
1 613-544-3310
-
Fax: 1 613-544-9666
-
Email: nazanin.alavi@queensu.ca